DANIEL ERNESTO
CASTELLANO GAUNA

Profesor asociado de Ciencias de la Salud

Foto de DANIEL ERNESTO

Foto de University of Bordeaux

University of Bordeaux

Burdeos, Francia

Publications in collaboration with researchers from University of Bordeaux (6)

2023

Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial (Nature Medicine, (2019), 25, 11, (1706-1714), 10.1038/s41591-019-0628-7)
Nature Medicine

2022

Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
European Urology, Vol. 82, Núm. 2, pp. 212-222

2021

Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial
European urology oncology, Vol. 4, Núm. 3, pp. 456-463

2020

Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial (Nature Medicine, (2019), 25, 11, (1706-1714), 10.1038/s41591-019-0628-7)
Nature Medicine

2019

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Nature Medicine, Vol. 25, Núm. 11, pp. 1706-1714

2013

Therapy management with sunitinib in patients with metastatic renal cell carcinoma: Key concepts and the impact of clinical biomarkers
Cancer Treatment Reviews, Vol. 39, Núm. 3, pp. 230-240